Saline Injection - Assisted Anesthesia in Eyelid Surgery

This study is currently recruiting participants.
Verified August 2011 by Sheba Medical Center
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01239498
First received: November 2, 2010
Last updated: August 7, 2011
Last verified: August 2011
  Purpose

The investigators hypothesize that injection of saline to the upper eyelids prior to lidocaine/adrenaline injection will reduce pain of the local anesthetic in comparison to injection of lidocaine alone.


Condition Intervention Phase
Blepharoptosis
Procedure: Injection of Saline + Lidocaine/Adrenaline
Procedure: Lidocaine/Adrenaline only
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Saline Injection - Assisted Anesthesia in Eyelid Surgery

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Primary Outcome Measures:
  • Patients' verbal pain scores will be elicited and documented immediately by the oculoplastic fellow [ Time Frame: 1-2 minutes ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: November 2010
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Saline + Lidocaine/Adrenaline Procedure: Injection of Saline + Lidocaine/Adrenaline

All anaesthetic injections will consist of xylocaine 1% with 1:100,000 adrenaline and will be administered through a short 30 Gauge needle at a constant slow speed at multiple (6-7) sites along the upper lid by a single oculoplastic consultant.

The experimental eyelid will receive a saline-consisted injection 0.5cc prior to the administration of the anesthetic injection.

Injection of Saline + Lidocaine 1%

Other Name: Local eyelid anesthesia
Placebo Comparator: Lidocaine/Adrenaline only Procedure: Lidocaine/Adrenaline only
Injection of Lidocaine/Adrenaline only
Other Name: Local eyelid anesthesia

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • patients undergoing bilateral upper eyelid surgery under local anaesthetic who have given fully informed consent to be in the trial

Exclusion Criteria:

  • Previous upper eyelid surgery
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01239498

Contacts
Contact: Ido Didi Fabian, MD +972547830444 didifabian@gmail.com

Locations
Israel
Goldschleger institute of ophthalmology, Sheba medical center Not yet recruiting
Ramat Gan, Israel
Contact: Ido Didi Fabian, MD     +972547830444     didifabian@gmail.com    
Goldschlager eye institute Recruiting
Ramat Gan, Israel
Contact: Ido Ido Fabian, MD         didifabian@gmail.com    
Sponsors and Collaborators
Sheba Medical Center
Investigators
Study Chair: Ido Didi Fabian, MD Sheba medical center, Goldschleger institute
  More Information

Publications:
Responsible Party: Ido Didi Fabian MD, Sheba medical center
ClinicalTrials.gov Identifier: NCT01239498     History of Changes
Other Study ID Numbers: SHEBA-10-8246-DF-CTIL
Study First Received: November 2, 2010
Last Updated: August 7, 2011
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Blepharoptosis
Eyelid Diseases
Eye Diseases
Epinephrine
Epinephryl borate
Lidocaine
Anesthetics
Adrenergic beta-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents
Therapeutic Uses
Mydriatics
Adrenergic alpha-Agonists
Sympathomimetics
Vasoconstrictor Agents
Cardiovascular Agents
Central Nervous System Depressants
Central Nervous System Agents
Anesthetics, Local
Sensory System Agents
Anti-Arrhythmia Agents

ClinicalTrials.gov processed this record on May 21, 2013